SEC Form 4 · accession 0001562180-17-000806
Sage Therapeutics, Inc. · SAGE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven M Paul
Director
Period of report
Jan 31, 2017
Accepted (ET)
Feb 17, 2017 · 5:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001597553
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 31, 2017 | J | 2,174 | $3.15 | A | 690,851 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reporting person did not directly purchase the shares. These shares were distributed to the reporting person as an investment in a private equity fund.